Medical Devices UAE

UAE Leadless Pacemakers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

UAE Leadless Pacemakers Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.0 Mn Placeholder estimate
Estimate 2025 $5.7 Mn 0.6% of the global market
Projected 2034 $17.5 Mn 210.1% Adds $11.9 Mn over 9 forecast years
CAGR 2025–2034 13.4% Faster than 82% of 173 Medical Devices markets here
Key players 5
  • UAE is 0.56% of the global market.
  • In Middle East, the largest is Saudi Arabia at $18.2 Mn.
  • Fastest growing: UAE (this report) at 13.4% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$11.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Leadless Pacemakers Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.0 Mn — —
2025 (base) $5.7 Mn +$0.7 Mn —
2026 (forecast) $6.4 Mn +$0.8 Mn +13.4%
2027 (forecast) $7.3 Mn +$0.9 Mn +28.6%
2028 (forecast) $8.3 Mn +$1.0 Mn +45.8%
2029 (forecast) $9.4 Mn +$1.1 Mn +65.4%
2030 (forecast) $10.6 Mn +$1.3 Mn +87.5%
2031 (forecast) $12.0 Mn +$1.4 Mn +112.7%
2032 (forecast) $13.6 Mn +$1.6 Mn +141.2%
2033 (forecast) $15.5 Mn +$1.8 Mn +173.5%
2034 (forecast) $17.5 Mn +$2.1 Mn +210.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.00 Bn
  2. North America $464.4 Mn
  3. US $363.2 Mn
  4. APAC $222.8 Mn
  5. Europe $191.4 Mn
  6. China $87.5 Mn
  7. Canada $77.6 Mn
  8. Japan $55.7 Mn
  9. Latin America $51.5 Mn
  10. Middle East $40.6 Mn
  11. Germany $33.4 Mn
  12. UK $27.8 Mn
  13. Brazil $28.9 Mn
  14. Italy $26.7 Mn
  15. France $26.2 Mn
  16. Spain $21.1 Mn
  17. India $20.2 Mn
  18. Ecuador $18.2 Mn
  19. Saudi Arabia $18.2 Mn
  20. Mexico $15.9 Mn
  21. Africa $13.3 Mn
  22. Australia $11.1 Mn
  23. Russia $9.5 Mn
  24. New Zealand $8.5 Mn
  25. South Africa $6.1 Mn
  26. UAE (this report) $5.7 Mn
  27. Egypt $2.9 Mn
  28. Philippines $2.4 Mn
  29. Hong Kong $1.8 Mn
  30. Malaysia $1.8 Mn
  31. Thailand $1.4 Mn
  32. Singapore $1.1 Mn
  33. Kenya $0.8 Mn

Report snapshot

UAE Leadless Pacemakers Market Analysis at a glance
Market size, 2025$5.7 Mn placeholder estimate
Forecast, 2034$17.5 Mn placeholder estimate
Growth (CAGR), 2025–203413.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, application and end user (see all)
Key playersMedtronic, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Leadless Pacemakers Market Analysis Executive Summary

Leadless pacemakers are tiny pacemakers placed directly inside the heart through a vein, with no wires under the skin.

Key segments of the leadless Pacemakers market include type (Single-Chamber and Dual-Chamber) and application (Bradycardia and AV Block).

Bar chart: UAE Leadless Pacemakers market size, 2024–2034, placeholder estimates. $5.0 Mn in 2024, $5.7 Mn in 2025 and $17.5 Mn in 2034, 13.4% CAGR.
UAE Leadless Pacemakers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Leadless Pacemakers Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the leadless Pacemakers market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the leadless Pacemakers market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the leadless Pacemakers market.

Competitive Landscape for Leadless Pacemakers Market in UAE

The leadless Pacemakers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Leadless Pacemakers Market in UAE

Leadless Pacemakers in the UAE: rules, payment and health figures

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2] Early deaths from long-term diseases: 6.8% in 2023, the latest WHO figure for the UAE.⁠[3]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how leadless Pacemakers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Leadless Pacemakers right now, from free public sources.

Latest research 467 papers since 2021 (worldwide)

  1. Leadless Versus Transvenous Pacing: Propensity-Matched 12-Month Outcomes. Pacing and clinical electrophysiology : PACE, 2026
  2. Temporal trends in permanent pacemaker implantations in France (2018-2024). Archives of cardiovascular diseases, 2026
  3. Adverse Event Profiles of Leadless Pacemaker Systems Reported to the FDA MAUDE Database (2021-2026). Journal of cardiovascular electrophysiology, 2026
  4. Endomyocardial biopsy after leadless pacemaker implantation in patient with suspected cardiac amyloidosis. Journal of cardiology cases, 2026
  5. Internal jugular vein approach facilitating second leadless pacemaker implantation after battery depletion. Journal of cardiology cases, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Leadless Pacemakers in context

The UAE compared

  • Early deaths from long-term diseases: 6.8% (2023). World: 17.2% (2023). 9th highest of the 9 countries we cover in Middle East.[1]
  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 9 countries we cover in Middle East.[2]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 3rd highest of the 9 countries we cover in Middle East.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Leadless Pacemakers market in the UAE?
Placeholder estimate: about $5.7 Mn in 2025, rising to about $17.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Leadless Pacemakers market in the UAE growing?
Placeholder estimate: about 13.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Leadless Pacemakers market report cover?
The report splits the market by type (Single-Chamber, Dual-Chamber), application (Bradycardia, AV Block) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Leadless Pacemakers market?
Key players include Medtronic, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation and Biotronik SE & Co. KG.
What is driving the Leadless Pacemakers market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the leadless Pacemakers market.
Who regulates Leadless Pacemakers in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
What does WHO report for the UAE?
Early deaths from long-term diseases: 6.8% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in the UAE are 65 or older?
1.8% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Leadless Pacemakers?
PubMed lists 467 papers on Leadless Pacemakers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Leadless Pacemakers in UAE? Our analysts can size it for your plan. Talk to us See the public data Early deaths from long-term diseases (WHO) for every country, free. Open the Public Health Dashboard

From our blog

Omega-3: Heart, Brain and the Evidence DebateOmega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart. Angiography: Seeing Inside the Blood VesselsCardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in… Angioplasty Balloons and Heart Care in IndiaIn 2017 India capped coronary stent prices, cutting drug-eluting stent prices by about 85%. Heart disease is…
Back to Catalogue
Keep exploring

Related Medical Devices reports in UAE

See all
Same topic, other categories

Related on cardiovascular

See the topic